SCHEMBL7205594

SCHEMBL7205594

CCOC(=O)Cn1cnc2c(N)nc(C(=O)OCc3ccccc3)nc21.Nc1ncnc2c1ncn2CC(=O)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 4/20 0.48
ADORA2A P29274 3/20 0.44
PI4KA P42356 2/20 0.44
PI4K2B Q8TCG2 2/20 0.44
PI4K2A Q9BTU6 2/20 0.44
PI4KB Q9UBF8 2/20 0.44
AHCY P23526 1/20 0.42
EP300 Q09472 2/20 0.41
KDR P35968 2/20 0.40
ALDH1A1 P00352 2/20 0.40
SRC P12931 1/20 0.40
ERBB2 P04626 1/20 0.40
BRAF P15056 1/20 0.40
TEK Q02763 1/20 0.40
AURKB Q96GD4 1/20 0.40
TSHR P16473 1/20 0.40
HTT P42858 1/20 0.40
LMNA P02545 1/20 0.39
HPGD P15428 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2153195 0.92 TSHR (0.45) EGFRADORA2AALDH1A1TSHRHTT
SCHEMBL2152998 0.87 EGFR (0.44) EGFRADORA2API4KAPI4K2BPI4K2A
SCHEMBL24709730 0.82 EGFR (0.65) EGFRADORA2API4KAPI4K2BPI4K2A
SCHEMBL6833359 0.80 PDE4A (0.47) EGFRADORA2API4KAPI4K2BPI4K2A
SCHEMBL1565498 0.79 ADORA2A (0.60) EGFRADORA2API4KAPI4K2BPI4K2A
SCHEMBL29728010 0.79 ADORA2A (0.60) EGFRADORA2API4KAPI4K2BPI4K2A
SCHEMBL454627 0.78 EGFR (0.47) EGFRADORA2AKDRALDH1A1SRC
SCHEMBL8340777 0.76 DAPK1 (0.46) KDRALDH1A1TSHRHPGDRAB9A
SCHEMBL19847491 0.75 MAPT (0.45) ADORA2AAHCYALDH1A1HTTLMNA
SCHEMBL6690200 0.74 TDP1 (0.49) ADORA2AALDH1A1TSHRHTTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6613873-B1 Covalently bound to a polyamide backbone; given formula; exhibit increased sequence specificity and binding affinity; resistant to enzyme degradation ISIS PHARMACEUTICALS, INC. 2003-09-02 US disclosed
US-6414112-B1 BIND COMPLEMENTARY NUCLEIC ACIDS MORE STRONGLY AND HAVE INCREASED SEQUENCE SPECIFICITY AND BINDING AFFINITY BUCHARDT OLE (DE) 2002-07-02 US disclosed